Vivos (RDGL) Shares Outstanding (Diluted) (2011 - 2025)
Vivos (RDGL) Shares Outstanding (Diluted) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | 580.70 Mn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | 457.00 Mn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | 393.60 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | 873.00 Mn |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 968.53 Mn |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | 452.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 452.72 Mn |
| Sep 30, 2025 | 454.30 Mn |
| Jun 30, 2025 | 453.51 Mn |
| Mar 31, 2025 | 448.23 Mn |
| Dec 31, 2024 | 409.67 Mn |
| Sep 30, 2024 | 418.63 Mn |
| Jun 30, 2024 | 403.38 Mn |
| Mar 31, 2024 | 389.41 Mn |
| Dec 31, 2023 | 368.81 Mn |
| Sep 30, 2023 | 370.54 Mn |
| Jun 30, 2023 | 368.17 Mn |
| Mar 31, 2023 | 362.54 Mn |
| Dec 31, 2022 | 351.43 Mn |
| Sep 30, 2022 | 343.91 Mn |
| Jun 30, 2022 | 343.91 Mn |
| Mar 31, 2022 | 13.87 Bn |
| Dec 31, 2021 | 13.87 Bn |
| Sep 30, 2021 | 13.87 Bn |
| Jun 30, 2021 | 13.87 Bn |
| Mar 31, 2021 | 13.87 Bn |